|
Merck & Co., Inc. (MRK) DCF Valuation
US | Healthcare | Drug Manufacturers - General | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Merck & Co., Inc. (MRK) Bundle
Simplify Merck & Co., Inc. (MRK) valuation with this customizable DCF Calculator! Featuring real Merck & Co., Inc. (MRK) financials and adjustable forecast inputs, you can test scenarios and uncover Merck & Co., Inc. (MRK) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46,840.0 | 41,518.0 | 48,704.0 | 59,283.0 | 60,115.0 | 64,483.9 | 69,170.4 | 74,197.4 | 79,589.8 | 85,374.1 |
| Revenue Growth, % | 0 | -11.36 | 17.31 | 21.72 | 1.4 | 7.27 | 7.27 | 7.27 | 7.27 | 7.27 |
| EBITDA | 16,009.0 | 10,180.0 | 17,899.0 | 21,315.0 | 6,907.0 | 18,428.5 | 19,767.8 | 21,204.5 | 22,745.6 | 24,398.6 |
| EBITDA, % | 34.18 | 24.52 | 36.75 | 35.95 | 11.49 | 28.58 | 28.58 | 28.58 | 28.58 | 28.58 |
| Depreciation | 3,652.0 | 3,486.0 | 3,214.0 | 3,909.0 | 3,872.0 | 4,620.5 | 4,956.3 | 5,316.5 | 5,702.9 | 6,117.4 |
| Depreciation, % | 7.8 | 8.4 | 6.6 | 6.59 | 6.44 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 |
| EBIT | 12,357.0 | 6,694.0 | 14,685.0 | 17,406.0 | 3,035.0 | 13,808.0 | 14,811.5 | 15,888.0 | 17,042.6 | 18,281.2 |
| EBIT, % | 26.38 | 16.12 | 30.15 | 29.36 | 5.05 | 21.41 | 21.41 | 21.41 | 21.41 | 21.41 |
| Total Cash | 10,450.0 | 8,062.0 | 8,096.0 | 13,192.0 | 7,093.0 | 11,917.0 | 12,783.0 | 13,712.1 | 14,708.6 | 15,777.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6,778.0 | 7,240.0 | 9,230.0 | 9,450.0 | 10,349.0 | 10,835.3 | 11,622.8 | 12,467.5 | 13,373.6 | 14,345.6 |
| Account Receivables, % | 14.47 | 17.44 | 18.95 | 15.94 | 17.22 | 16.8 | 16.8 | 16.8 | 16.8 | 16.8 |
| Inventories | 5,978.0 | 6,310.0 | 5,953.0 | 5,911.0 | 6,358.0 | 7,832.3 | 8,401.6 | 9,012.1 | 9,667.1 | 10,369.7 |
| Inventories, % | 12.76 | 15.2 | 12.22 | 9.97 | 10.58 | 12.15 | 12.15 | 12.15 | 12.15 | 12.15 |
| Accounts Payable | 3,738.0 | 4,327.0 | 4,609.0 | 4,264.0 | 3,922.0 | 5,362.8 | 5,752.5 | 6,170.6 | 6,619.1 | 7,100.1 |
| Accounts Payable, % | 7.98 | 10.42 | 9.46 | 7.19 | 6.52 | 8.32 | 8.32 | 8.32 | 8.32 | 8.32 |
| Capital Expenditure | -3,473.0 | -4,684.0 | -4,448.0 | -4,388.0 | -3,863.0 | -5,372.4 | -5,762.9 | -6,181.7 | -6,630.9 | -7,112.9 |
| Capital Expenditure, % | -7.41 | -11.28 | -9.13 | -7.4 | -6.43 | -8.33 | -8.33 | -8.33 | -8.33 | -8.33 |
| Tax Rate, % | 80.68 | 80.68 | 80.68 | 80.68 | 80.68 | 80.68 | 80.68 | 80.68 | 80.68 | 80.68 |
| EBITAT | 10,609.7 | 5,381.2 | 13,806.8 | 15,368.4 | 586.4 | 10,159.5 | 10,897.9 | 11,689.9 | 12,539.5 | 13,450.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 1,770.7 | 3,978.2 | 11,221.8 | 14,366.4 | -1,092.6 | 8,887.8 | 9,124.4 | 9,787.5 | 10,498.8 | 11,261.9 |
| WACC, % | 6.07 | 6.04 | 6.11 | 6.08 | 5.7 | 6 | 6 | 6 | 6 | 6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 41,454.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 11,487 | |||||||||
| Terminal Value | 287,139 | |||||||||
| Present Terminal Value | 214,562 | |||||||||
| Enterprise Value | 256,016 | |||||||||
| Net Debt | 29,359 | |||||||||
| Equity Value | 226,657 | |||||||||
| Diluted Shares Outstanding, MM | 2,547 | |||||||||
| Equity Value Per Share | 88.99 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real MRK financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the highlighted cells).
- Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Merck's valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation frameworks tailored for Merck & Co., Inc. (MRK).
- WACC Calculator: Pre-designed Weighted Average Cost of Capital sheet with adjustable inputs specific to the pharmaceutical sector.
- Customizable Forecast Assumptions: Adjust growth projections, capital expenditures, and discount rates as per Merck's market dynamics.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Merck & Co., Inc. (MRK).
- Visual Dashboard and Charts: Graphical representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based MRK DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Merck’s intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Merck & Co., Inc. (MRK)?
- All-in-One Solution: Incorporates DCF, WACC, and financial ratio analyses tailored for Merck.
- Flexible Inputs: Modify yellow-highlighted fields to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Merck’s intrinsic value and Net Present Value.
- Preloaded Information: Historical and projected data provide reliable starting points for analysis.
- High-Quality Standards: Perfect for financial analysts, investors, and business advisors focusing on Merck.
Who Should Use This Product?
- Investors: Evaluate Merck’s valuation prior to buying or selling stocks.
- CFOs and Financial Analysts: Optimize valuation processes and assess financial projections.
- Startup Founders: Understand how large public companies like Merck are valued.
- Consultants: Provide expert valuation reports for clients.
- Students and Educators: Utilize real-world data to practice and teach valuation methodologies.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring intricate valuation calculations.
- Real-World Data: Merck & Co., Inc.'s (MRK) historical and projected financials preloaded for analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables presenting clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.